IMPERIAL AND COP26
Imperial shapes its role in the UN Climate Change Conference COP26
The whole Imperial community is invited to get involved in a year of action on climate change and biodiversity loss.
Imperial shapes its role in the UN Climate Change Conference COP26
The whole Imperial community is invited to get involved in a year of action on climate change and biodiversity loss.
Imperial College Innovation Fund backs startup developing Parkinson's wearable
The Imperial College Innovation Fund has made its first investment into a startup developing a non-invasive device to help manage Parkinson's symptoms
Imperial students launch educational platform to boost diversity in STEM
Accelerate aims to support students from underrepresented backgrounds to secure university offers, internships and graduate jobs.
2
Imperial graduate develops smart mask to track wearer’s respiratory patterns
A startup founded by an Imperial graduate has created a ‘smart mask’ that displays respiratory information in real time.
Smart toilets and managing natural disasters: designing cities of the future
Imperial students have collaborated with students from Tsinghua University in Beijing to devise solutions for the smart cities of the future.
Ceres Power progresses toward mass production of SOFC systems
Ceres Power, founded based on Imperial research and now one of the UK’s most valuable cleantech companies, announces collaboration with Bosch
Imperial convenes industry and government partners to discuss innovation policy
Imperial and CaSE held a roundtable with industry, academic and Government partners to discuss next steps for UK innovation policy.
Future visions and better balance: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Imperial graduate launches app to help early diagnosis of dementia
A startup founded by an Imperial graduate has launched the first app to contribute to early diagnosis of dementia through artificial intelligence.
1
Imperial startup wins £4.5m investment to develop new cancer drugs
An Imperial startup has won £4.5m investment to develop drugs that could offer a safer and more effective way to treat certain drug-resistant cancers.
3